Natural IgG protects against early dissemination of vesicular stomatitis virus.

Early infection FcRn blocker Natural IgG Neutralizing IgG Vaccination

Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
15 May 2024
Historique:
received: 06 11 2023
revised: 25 03 2024
accepted: 16 04 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 16 5 2024
Statut: aheadofprint

Résumé

Neonatal Fc receptor (FcRn) recycles immunoglobulin G, and inhibition of FcRn is used clinically for treatment of autoimmune diseases. In this work, using the vesicular stomatitis virus (VSV) mouse infection model system, we determined the role of FcRn during virus infection. While induction of neutralizing antibodies and long-term protection of these antibodies was hardly affected in FcRn deficient mice, FcRn deficiency limited the amount of natural IgG (VSV-specific) antibodies. Lack of natural antibodies (nAbs) limited early control of VSV in macrophages, accelerated propagation of virus in several organs, led to the spread of VSV to the neural tissue resulting in fatal outcomes. Adoptive transfer of natural IgG into FcRn deficient mice limited early propagation of VSV in FcRn deficient mice and enhanced survival of FcRn knockout mice. In line with this, vaccination of FcRn mice with very low dose of VSV prior to infection similarly prevented death after infection. In conclusion we determined the importance of nAbs during VSV infection. Lack of FcRn limited nAbs and thereby enhanced the susceptibility to virus infection.

Identifiants

pubmed: 38754237
pii: S0896-8411(24)00064-7
doi: 10.1016/j.jaut.2024.103230
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103230

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts of interest.

Auteurs

Abdelrahman Elwy (A)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany. Electronic address: abdelrahman.elwy@uk-essen.de.

Hossam Abdelrahman (H)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany.

Julia Specht (J)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany.

Swati Dhiman (S)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany.

Theresa Charlotte Christ (TC)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany.

Judith Lang (J)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany.

Justa Friebus-Kardash (J)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, 45147, Essen, Germany.

Mike Recher (M)

Immunodeficiency Laboratory, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.

Karl Sebastian Lang (KS)

Institute of Immunology, Medical Faculty, University of Duisburg-Essen, 45147, Essen, Germany. Electronic address: karlsebastian.lang@uk-essen.de.

Classifications MeSH